Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Globus Medical is a medical devices business based in the US. Globus Medical shares (GMED) are listed on the NYSE and all prices are listed in US Dollars. Globus Medical employs 2,400 staff and has a trailing 12-month revenue of around $998.4 million.
Finder Award
SoFi Invest
tastyworks
| Latest market close | $75.86 |
|---|---|
| 52-week range | $52.60 - $81.78 |
| 50-day moving average | $72.09 |
| 200-day moving average | $65.09 |
| Wall St. target price | $78.29 |
| PE ratio | 47.8452 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.55 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $75.86 from 2023-01-27
| 1 week (2023-01-20) | 2.44% |
|---|---|
| 1 month (2022-12-28) | 4.23% |
| 3 months (2022-10-28) | 12.87% |
| 6 months (2022-07-28) | 29.04% |
| 1 year (2022-01-26) | 16.37% |
|---|---|
| 2 years (2021-01-28) | 20.39% |
| 3 years (2020-01-28) | 41.74% |
| 5 years (2018-01-26) | 61.20% |
Valuing Globus Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Globus Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Globus Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 48x. In other words, Globus Medical shares trade at around 48x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Globus Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.928. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Globus Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Globus Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $268.7 million.
The EBITDA is a measure of a Globus Medical's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $998.4 million |
|---|---|
| Operating margin TTM | 20.09% |
| Gross profit TTM | $718.9 million |
| Return on assets TTM | 6.45% |
| Return on equity TTM | 8.91% |
| Profit margin | 15.55% |
| Book value | $17.67 |
| Market capitalisation | $7.4 billion |
TTM: trailing 12 months
We're not expecting Globus Medical to pay a dividend over the next 12 months.
Over the last 12 months, Globus Medical's shares have ranged in value from as little as $52.6 up to $81.78. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Globus Medical's is 1.0063. This would suggest that Globus Medical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Globus Medical, Inc. , a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
